Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase
β Scribed by Peter G. Steinherz
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 731 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BACKGROUND. L-asparaginase in combination with methotrexate has synergistic antileukemic activity in a schedule-dependent fashion. A new preparation of L-asparaginase, polyethylene-glycol conjugated (PEG)-asparaginase, is a pharmacologically different formulation of L-asparaginase with distinct prop
## Abstract Fortyβfive children with acute nonlymphoblastic leukemia in relapse received a total of 56 courses of Lβasparaginase combined with vincristine and prednisone. The complete remission rate of 40% (12 of 30 trials) in patients resistant to vincristine and prednisone was almost identical to
The authors report five pediatric patients with acute lymphoblastic leukemia (ALL) in whom symptomatic aseptic osteonecrosis developed on therapy. All patients had been on treatment with a modified BFM protocol and developed osteonecrosis in the maintenance phase of the protocol. The avascular necro
FL 33612 to permit rapid consideration for publication. ## Recurrent Lymphocytic Pleural Effusion After Intravenous Immunoglobulin To the Editor: A 35-year-old female was initially diagnosed in 1981 with stage IIA Hodgkin's disease treated successfully with MOPP (mechlorethamine, oncovin, procarb